Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study-Reference-Cited by-同舟云学术

Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study

Published:2022-09-26 Issue:4 Volume:12 Page:5158-5171
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Zhao Rui¹,Ren Shuai¹^ORCID,Li Changyin²,Guo Kai¹^ORCID,Lu Zipeng³,Tian Lei³,He Jian⁴,Zhang Kai³^ORCID,Cao Yingying¹^ORCID,Liu Shijia⁵,Li Donghui⁶,Wang Zhongqiu¹^ORCID

Affiliation:

1. Department of Radiology, Jiangsu Province Hospital of Chinese Medicine Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing China

2. Department of Clinical Pharmacology, Jiangsu Province Hospital of Chinese Medicine Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing China

3. Pancreas Center The First Affiliated Hospital with Nanjing Medical University Nanjing China

4. Department of Nuclear Medicine, Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing China

5. Department of Pharmacy, Jiangsu Province Hospital of Chinese Medicine Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing China

6. Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5296

Reference43 articles.

1. Cancer Statistics, 2021

2. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis

3. Distant metastasis occurs late during the genetic evolution of pancreatic cancer

4. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

5. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach;Computational Biology and Chemistry;2024-10

2. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review;Journal of Experimental & Clinical Cancer Research;2024-09-02

3. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20

4. Case Study on Analysing the Early Disease Detection of Pancreatic Ductal Adenocarcinoma in Korean Association for Clinical Oncology;American Journal of Clinical Oncology;2024-07-04

5. Metabolomics for searching validated biomarkers in cancer studies: a decade in review;Expert Review of Molecular Diagnostics;2024-06-21